Patients with type 2 diabetes mellitus （T2DM） exhibit hyperglycemia and hyperinsulinemia and increased risk of fracture at early stage, but they were found to have normal or even enhanced bone mineral density （BMD）. This study was aimed to examine the molecular mechanisms governing changes in bone structure and integrity under both hyperglycemic and hyperinsulinemic conditions. Monocytes were isolated from the bone marrow of the C57BL/6 mice, induced to differentiate into os- teoclasts by receptor activator of nuclear factor kappa-B ligand （RANKL） and macrophage col- ony-stimulating factor （M-CSF） and exposed to high glucose （33.6 mmol/L）, high insulin （1 ~nol/L）, or a combination of high glucose/high insulin （33.6 mmol/L glucose and 1 Ixmol/L insulin）. Cells cultured in u-MEM alone served as control. After four days of incubation, the cells were harvested and stained for tartrate resistant acid phosphatase （TRAP）. Osteoclast-related genes including RANK, cathepsin K and TRAP were determined by using real-time PCR. The resorptive activity of osteoclasts was measured by using a pit formation assay. Osteoclasts that were derived from monocytes were of multinucleated nature and positive for TRAP, a characteristic marker of osteoclasts. Cell counting showed that the number of osteoclasts was much less in high glucose and high glucose/high insulin groups than in nor- mal glucose and high insulin groups. The expression levels of RANK and cathepsin K were signifi- cantly decreased in high glucose, high insulin and high glucose/high insulin groups as compared with normal glucose group, and the TRAP activity was substantially inhibited in high glucose environment. The pit formation assay revealed that the resorptive activity of osteoclasts was obviously decreased in high glucose group and high glucose/high insulin group as compared with normal group. It was concluded that osteoclastogenesis is suppressed under hyperglycemic and hyperinsulinemic conditions, suggesting a disruption of the bon
